Technical Analysis for ISR - IsoRay, Inc.

Grade Last Price % Change Price Change
grade B 0.39 5.41% 0.02
ISR closed up 5.41 percent on Thursday, November 14, 2019, on 5.3 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ISR trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Resistance Bearish 5.41%
Gilligan's Island Sell Setup Bearish Swing Setup 5.41%

Older signals for ISR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
ISR Chart by TradingView
Basic chart:
Profile
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.
Medicine Health Cancer Treatment Of Cancer Oncology Radiation Prostate Cancer Breast Cancer Medical Physics Radiation Therapy Colorectal Cancer Pancreatic Cancer Brain Cancer Treatment Of Prostate Cancer Esophageal Cancer Balloon Catheter Brachytherapy Liver Cancer Ocular Melanoma Pancreatic Cancers
Is ISR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 14 81 Biggest Movers From Yesterday
Nov 13 What Makes IsoRay (ISR) a New Strong Buy Stock
Nov 12 IsoRay, Inc. (ISR) CEO Lori Woods on Q1 2020 Results - Earnings Call Transcript
Nov 12 IsoRay (ISR) Reports Q1 Loss, Tops Revenue Estimates
Nov 12 IsoRay EPS beats by $0.01, beats on revenue
Nov 12 Isoray Announces Record First Quarter Fiscal 2020 Financial Results
Nov 5 Will IsoRay (ISR) Report Negative Earnings Next Week? What You Should Know
Nov 1 We Think IsoRay (NYSEMKT:ISR) Needs To Drive Business Growth Carefully
Oct 31 Isoray To Announce First Quarter Fiscal 2020 Financial Results on November 12, 2019
Oct 29 Isoray Will Have Prominent Role at American Brachytherapy Society’s Annual Prostate Brachytherapy Workshop
See more ISR news...
Indicators
Indicator Value
52 Week High 0.495
52 Week Low 0.269
Average Volume 167,616
200-Day Moving Average 0.3792
50-Day Moving Average 0.328
20-Day Moving Average 0.3239
10-Day Moving Average 0.3394
Average True Range 0.0248
ADX 17.42
+DI 29.4661
-DI 9.0909
Chandelier Exit (Long, 3 ATRs ) 0.3456
Chandelier Exit (Short, 3 ATRs ) 0.3619
Upper Bollinger Band 0.3692
Lower Bollinger Band 0.2786
Percent B (%b) 1.23
BandWidth 27.971596
MACD Line 0.0101
MACD Signal Line 0.0022
MACD Histogram 0.0079
Fundamentals Value
Market Cap 21.45 Million
Num Shares 55 Million
EPS -0.11
Price-to-Earnings (P/E) Ratio -3.48
Price-to-Sales 5.78
Price-to-Book 2.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.44
Resistance 3 (R3) 0.43 0.42 0.43
Resistance 2 (R2) 0.42 0.41 0.42 0.42
Resistance 1 (R1) 0.40 0.40 0.41 0.41 0.42
Pivot Point 0.39 0.39 0.39 0.39 0.39
Support 1 (S1) 0.37 0.38 0.38 0.38 0.36
Support 2 (S2) 0.36 0.37 0.36 0.36
Support 3 (S3) 0.34 0.36 0.35
Support 4 (S4) 0.35